Literature DB >> 276885

Modification of conditioned behavior of rats by neurohypophyseal hormones and analogues.

R Walter, J M van Ree, D de Wied.   

Abstract

Vasopressin and other neurohypophyseal peptides affect various processes related to memory and/or learning. A single subcutaneous injection of vasopressin increases resistance to extinction of a pole-jumping avoidance response in rat. This test system has been applied in an attempt to relate structural aspects of neurohypophyseal peptides, analogues, and derivatives with truncated sequences to their effects on conditioned behavior. Thus far it can be concluded that there are more stringent requirements on certain residues in the 20-member covalent ring than in positions 8 and 9 of the linear peptide portion for neurohypophyseal hormones to be active. Critical are the contributions of residues in positions 2, 3, and 5; these results are reminiscent of those from conformation-activity correlations of the endocrine effects of neurohypophyseal hormones, in which the side chain of the residue in position 3 is critical for receptor binding and the side chains of residues in positions 2 and 5 are key for the activation of the receptor. Chemical modifications in position 4 yield analogues that are active and inactive in increasing the resistance to extinction of the avoidance response, depending on the particular structural substitution, similar to results from structure-activity studies of the endocrine activities of neurohypophyseal hormones. Because behavioral activities of vasopressin are more tolerant than endocrine activities to modifications of the hormone in positions 8 and 9, analogues with the most striking dissociation of potencies in learned behavior and endocrine responses are expected to be those with sequence alterations in the linear peptide portion. Peptides with linear part sequences of neurohypophyseal hormones showed little or no activity. The results obtained in this structure-activity study are compared with those of an earlier study in which the ability of various neurohypophyseal peptides to attenuate puromycin-induced amnesia in mice was evaluated.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 276885      PMCID: PMC392580          DOI: 10.1073/pnas.75.5.2493

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence.

Authors:  J M van Ree; D de Wied
Journal:  Life Sci       Date:  1976-11-01       Impact factor: 5.037

2.  Indentification of sites in oxytocin involved in uterine receptor recognition and activation.

Authors:  P Walter
Journal:  Fed Proc       Date:  1977-05

Review 3.  Oxytocin analogs in the analysis of some phases of hormone action.

Authors:  J Rudinger; V Pliska; I Krejcí
Journal:  Recent Prog Horm Res       Date:  1972

4.  Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats.

Authors:  D De Wied
Journal:  Nature       Date:  1971-07-02       Impact factor: 49.962

5.  Dissociation of the behavioural and endocrine effects of lysine vasopressin by tryptic digestion.

Authors:  D de Wied; H M Greven; S Lande; A Witter
Journal:  Br J Pharmacol       Date:  1972-05       Impact factor: 8.739

6.  Conformation of lysine vasopressin: a comparison with oxytocin.

Authors:  R Walter; J D Glickson; I L Schwartz; R T Havran; J Meienhofer; D W Urry
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

7.  Synthesis and some of the pharmacological properties of (4-leucine)-8-lysine-vasopressin and (1-deamino,4-leucine)-8-lysine-vasopressin.

Authors:  D F Dyckes; M F Ferger; V Du Vigneaud; W Y Chan
Journal:  J Med Chem       Date:  1973-07       Impact factor: 7.446

8.  Structural changes in the arginine vasopressin molecule that enhance antidiuretic activity and specificity.

Authors:  W H Sawyer; M Acosta; L Balaspiri; J Judd; M Manning
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

9.  Dose-response relationships in attenuation of puromycin-induced amnesia by neurohypophyseal peptides.

Authors:  J B Flexner; L B Flexner; P L Hoffman; R Walter
Journal:  Brain Res       Date:  1977-09-23       Impact factor: 3.252

10.  Importance of the third amino acid residue of oxytocin for its action on isolated rat uterus: study of relationship between hormone conformation and activity.

Authors:  R Walter; C W Smith; J Roy
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

View more
  7 in total

1.  Inhibition by Z-Pro-D-Leu of development of tolerance to and physical dependence on morphine in mice.

Authors:  R Walter; R F Ritzmann; H N Bhargava; T C Rainbow; L B Flexner; W A Krivoy
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

2.  Immunocytochemistry of magnocellular neurons of supraoptic and paraventricular nuclei of normal and Brattleboro rats with vasopressin anti-idiotype antibody.

Authors:  K M Knigge; D T Piekut; D J Berlove
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  Two classes of arginine vasopressin binding sites on rat brain membranes.

Authors:  J T Junig; L G Abood; A M Skrobala
Journal:  Neurochem Res       Date:  1985-09       Impact factor: 3.996

4.  Effects of vasopressin, des-glycinamide vasopressin and amphetamine on a combined passive and active avoidance task.

Authors:  A Sahgal
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 5.  A critique of the vasopressin-memory hypothesis.

Authors:  A Sahgal
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Solubilization and purification of the Ni-stimulated arginine-vasopressin binding site of rat brain membranes.

Authors:  J T Junig; L G Abood
Journal:  Neurochem Res       Date:  1987-09       Impact factor: 3.996

7.  Central administration of arginine vasotocin: effects on exploratory behavior in the rat.

Authors:  M G King; L Stinus; M le Moal; M Geffard
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.